Literature DB >> 12150332

Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: evidence for a subclinical cardiomyopathy.

N Ozbey1, A Sezgil, H Oflaz, B Umman, Y Orhan, E Sencer, S Molvalilar.   

Abstract

The aim of this study was to evaluate cardiac performance, in particular diastolic function, in adult patients with adulthood onset GH deficiency. The study group was composed of 19 GH deficient adult hypopituitary patients with at-least 3 additional pituitary hormone deficits and 19 age, sex and BMI matched healthy controls. Mean duration of hypopituitarism was 108.6 +/- 77.0 months. None of the patients and controls presented with or had previous diagnosis of concomitant diseases that could affect cardiac function. All hormone deficiencies, except for GH, were appropriately replaced in the patients. Left ventricular function and geometry were evaluated by two-dimensional, M-mode and Doppler echocardiography. Body composition was evaluated by bioelectrical impedance analysis. Not significant differences were observed with respect to left heart dimensions and left ventricular systolic function between patients and controls. Nevertheless 2 of the left ventricular diastolic function parameters, deceleration time and isovolumetric relaxation time, were significantly prolonged in the patients compared with controls (247.88 +/- 70.65 vs 143.26 +/- 31.70 milliseconds (ms) and 122.31 +/- 18.24 vs 89.47 +/- 12.12 ms respectively, p<0.001). Duration of hypopituitarism was significantly correlated with percent body fat mass (r=0.6119, p<0.01) and percent lean body mass (r=-0.5949, p<0.01). It is concluded that in adults affected by hypopituitarism, GH deficiency predominantly impairs diastolic function while systolic function at rest is spared. This observation might indicate a preclinical stage of a cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150332     DOI: 10.1007/BF03345081

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  GH deficiency in adults: an epidemiological approach.

Authors:  G Sassolas; F B Chazot; P Jaquet; I Bachelot; P Chanson; C C Rudelli; J P Tauber; H Allannic; J Bringer; N Roudaut; V Rohmer; P Roger; J L Latapie; P Reville; M Leutenegger
Journal:  Eur J Endocrinol       Date:  1999-12       Impact factor: 6.664

2.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

3.  Cardiac hypertrophy: the consequences for diastole.

Authors:  B H Lorell; W Grossman
Journal:  J Am Coll Cardiol       Date:  1987-05       Impact factor: 24.094

4.  Adults with childhood-onset growth hormone deficiency: effects of growth hormone treatment on cardiac structure.

Authors:  A Sartorio; S Ferrero; A Conti; R Bragato; G Malfatto; G Leonetti; G Faglia
Journal:  J Intern Med       Date:  1997-06       Impact factor: 8.989

5.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

6.  Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency.

Authors:  J C ter Maaten; H de Boer; O Kamp; L Stuurman; E A van der Veen
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

7.  Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.

Authors:  F P Dunne; P Elliot; M D Gammage; T Stallard; T Ryan; M C Sheppard; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

8.  Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults.

Authors:  L Thuesen; J O Jørgensen; J R Müller; B O Kristensen; N E Skakkebaek; N Vahl; J S Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

9.  The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism.

Authors:  A A Toogood; C G Beardwell; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

10.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

View more
  3 in total

1.  Structural, functional and autonomic changes in the cardiovascular system in growth hormone deficient patients.

Authors:  Doğan Erdoğan; Tufan Tükek; Ferihan Aral; Hüseyin Oflaz; Mehmet Ozaydin; Orhan Kocaman; Vakur Akkaya; Taner Gören; Senay Molvalilar
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

2.  One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.

Authors:  Mara Boschetti; Sergio Agosti; Valeria Albanese; Laura Casalino; Claudia Teti; Gian Paolo Bezante; Claudio Brunelli; Manuela Albertelli; Diego Ferone
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

3.  Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study.

Authors:  Cesare de Gregorio; Lorenzo Curtò; Antonino Recupero; Patrizia Grimaldi; Barbara Almoto; Marilena Venturino; Domenico Cento; Maria Carola Narbone; Francesco Trimarchi; Sebastiano Coglitore; Salvatore Cannavò
Journal:  BMC Endocr Disord       Date:  2006-02-28       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.